David L. Wilke

Bio

David focuses his practice on the representation of emerging growth technology companies, as well as the venture capital and private equity firms that fund these companies. He is the leader of the firm’s Private Equity and Clean Tech Industry Teams and is a member of the firm’s Executive Committee.

David has represented technology companies in a variety of transactions, including private and public offerings, technology partnerships and licensing arrangements, and mergers and acquisitions. As counsel to venture capital and private equity funds, he assists with fund formation matters and the full spectrum of these funds’ investment transactions, including debt and equity financings, leveraged acquisitions, divestitures, restructurings, and co-investments.

David received his law degree from Stanford Law School and served as an Associate Editor of the Stanford Law Review. He completed his bachelor’s degree at the University of Illinois at Urbana-Champaign, where he graduated with honors and was elected to Phi Beta Kappa. Prior to joining the firm in 2000, David practiced in the Silicon Valley office of Cooley Godward LLP.

Practice Areas

Investment Funds

The Investment Funds practice group is an interdisciplinary team of attorneys who focus on formation and management of private investment funds, and representation of fund sponsors, managers, advisers, and investors. We provide legal counsel in all relevant areas, including fund structure, tax planning, securities laws, internal ownership and control, regulatory, and other legal matters.

Capital Markets

Our Capital Markets practice group focuses on assisting clients in financing transactions. From start-ups seeking seed or venture capital to larger private and public equity and debt financings, our experience and expertise helps clients close successful deals.

Mergers & Acquisitions

Our M&A practice group is composed of experienced transactional attorneys focused on handling the complexities of M&A transactions. We take pride in working closely with our clients at every stage of the process, from pre-transaction preparation and deal structuring in order to maximize value and minimize risk, through due diligence, to drafting and negotiating definitive agreements, and ultimately to closing and post-closing advice.

Emerging Companies

For over 40 years, we have helped founders, start-ups, and emerging companies form, finance, and grow their businesses, and have assisted countless angel investors and venture capital firms with their investment activities.

Life Sciences

The Wyrick Robbins Life Sciences Industry Team focuses on serving the special needs of participants in traditional and emerging life sciences markets, including biotechnology, pharmaceuticals, medical devices, diagnostics, contract research and laboratory services, agricultural biotechnology, and drug discovery tools.